NEWSLETTER
ISSUE
Jan to Apr, 2018 Volume 5
Pharmalab’ s partner Aseptic Technologies successfully put in operation its Crystal® L1 Robotic Filling Line within in an Isolator at Midatech Pharma, Spain.
To move forward in the clinical trials of their innovative nanoparticle-based product against rare cancers, the company Midatech Pharma is now using a Crystal® L1 Robotic Line.
Midatech Pharma is presently scaling-up clinical-grade therapeutics based on their Gold Nanoparticle Technology Platform drug conjugate technology and other nanopharmaceuticals.
Last August the Crystal® L1 Robotic Line was successfully put in operation within as isolator at Midatech site in Spain to bolster clinical trials, which is believed to be the first licensed nanopharmaceutical cGMP facility of its kind in Europe. We are delighted to collaborate with Midatech Pharma and to contribute to the development of this pioneering therapeutic field, by bringing our expertise in the aseptic processing of injectables.
We are delighted to collaborate with Midatech Pharma and to contribute to the development of this pioneering therapeutic field, by bringing our expertise in the aseptic processing of injectables.
Meanwhile, other Crystal® L1 Robotic Lines are on their way to US, Europe and Asia, supporting product development and scaling-up of other AT-Closed Vial® users.
Pharmalab have collaborated with Aseptic Technologies to support Indian Pharmaceutical industry in process of aseptic filling. Aseptic Technologies is renowned worldwide for its AT-Closed Vial® Technology used for filling pre-sterilized vials to reduce the risk of batch contamination and simplifying the fill and finish of the drug.
For more details click here
